# Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults

> **NCT00258947** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 230 (actual)

## Conditions studied

- Smallpox
- Poxvirus Infection

## Interventions

- **BIOLOGICAL:** Smallpox vaccine, LISTER strain, from chick embryo cells

## Key facts

- **NCT ID:** NCT00258947
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2006-12
- **Final completion:** 2007-01
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2012-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00258947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00258947, "Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00258947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*